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Abstract
Background: Staphylococcus aureus infection of normal osteoblasts induces expression of tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL).
Results: Normal osteoblasts were incubated in the presence of purified bacterial products over a
range of concentrations. Results demonstrate that purified surface structures and a selected
superantigen present in the extracellular environment are not capable of inducing TRAIL
expression by osteoblasts. Osteoblasts were co-cultured with S. aureus at various multiplicities of
infection utilizing cell culture chamber inserts. Results of those experiments suggest that direct
contact between bacteria and osteoblasts is necessary for optimal TRAIL induction. Finally, S.
aureus infection of osteoblasts in the presence of anti-TRAIL antibody demonstrates that TRAIL
mediates caspase-8 activation and apoptosis of infected cells.
Conclusions: Collectively, these findings suggest a mechanism whereby S. aureus mediates bone
destruction via induction of osteoblast apoptosis.
Background
Staphylococcus aureus is the most common cause of osteo-
myelitis, a disease often refractory to treatment and sub-
ject to recurrence. Traditional treatment for osteomyelitis
involves surgical debridement of infected tissue, coupled
with systemic antibiotic therapy. Only a few decades ago,
the majority of S. aureus strains associated with osteomy-
elitis were susceptible to antibiotics including methicillin.
However, the emergence of antibiotic resistance among
strains of S. aureus has rendered methicillin and many
other antibiotics less effective against this organism. Con-
sequently, there is an urgent need for the development of
novel therapies for the treatment of osteomyelitis.
S. aureus is a capable bone pathogen, in part, because it
possesses several cell surface adhesion molecules that fa-
cilitate its binding to bone matrix. Binding involves a fam-
ily of adhesins that interact with extracellular matrix
components, and these adhesins have been termed micro-
bial surface components recognizing adhesive matrix
molecules (MSCRAMMs) [1]. Specific MSCRAMMs are re-
sponsible for localization of S. aureus to particular tissues,
and include fibronectin-binding proteins (FnBPs) [2,3],
fibrinogen-binding proteins [4–6], elastin-binding adhes-
in [7] collagen-binding adhesion [8], and a broad-specifi-
city adhesin (MAP) that facilitates low-affinity binding of
S. aureus to several proteins, including osteopontin,
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collagen, bone sialoprotein, fibronectin, fibrinogen, and
vitronectin [9]. S. aureus can utilize MSCRAMMs to adhere
directly to cells or can attach to cells through the use of
bridging ligands such as Hsp60 which has an affinity for
both MSCRAMMs and the β1-integrin host cell receptor
[10,11]. Interaction of S. aureus with host cells via
MSCRAMMs can induce signal transduction, tyrosine ki-
nase activity, and cytoskeletal rearrangement [12].
Compared to other bacteria, S. aureus is generally not con-
sidered a significant intracellular pathogen. Staphylococci
have typically been regarded as non-invasive extracellular
pathogens that damage host cells after adhering to the ex-
tracellular matrix; however, there is growing evidence that
S. aureus has the ability to invade and persist within eu-
karyotic cells. S. aureus has been shown to be ingested by
non-professional phagocytes, such as mouse fibroblasts
[13], mouse renal cells [14], and bovine mammary epi-
thelial cells [15,16]. S. aureus also has the ability to invade
mouse and human osteoblast cell lines [17,18], as well as
normal mouse and human osteoblasts [19]. Finally, S. au-
reus has been shown to invade normal chick osteoblasts
both in vitro and in vivo [20,21]. S. aureus cells were
found in approximately 14% of calvarial osteoblasts after
subcutaneous injection of chick embryos, and in 11% of
calvarial and tibial osteoblasts following intra-allantoic
injection. Similar to most in vitro studies, the majority of
intracellular bacteria are eventually free in the osteoblast
cytoplasm in vivo. S. aureus cells in calvariae and tibiae
were also observed in the cytoplasm of approximately 4%
of the osteocytes in mineralized bone matrix. Therefore,
osteoblasts containing internalized S. aureus cells contin-
ue differentiating into osteocytes. In addition, S. aureus in-
vasion of osteoblasts stimulates the secretion of
interleukin (IL)-6, IL-12, and colony-stimulating factors
[19,22,23]. These cytokines can potentially exacerbate the
bone destruction already characteristic of infection by ac-
tivation of osteoclasts. In addition to osteoclast activation,
S. aureus inhibits bone-matrix synthesis, further com-
pounding bone loss observed with osteomyelitis [24].
The ability of S. aureus to survive in the eukaryotic intrac-
ellular environment could explain several aspects of
chronic staphylococcal diseases and long-term coloniza-
tion. Internalization may provide a means of protection
against host defenses and certain classes of antibiotics.
Many staphylococcal infections which tend to become
chronic (e.g., osteomyelitis and mastitis) are associated
with multiple recurrences and do not resolve even in the
presence of what seems to be an adequate humoral im-
mune response [25–28]. For example, patients can have
recurrent attacks of osteomyelitis after completion of
treatment, even when causative organisms cannot be iso-
lated [25].
Staphylococcal infections are typically associated with
death of tissue, and evidence suggests intracellular bacte-
ria are capable of inducing apoptosis. S. aureus-mediated
apoptosis has been reported in epithelial cells [16,29,30],
keratinocytes [31], endothelial cells [32,33], and osteob-
lasts [34]. The two global gene regulatory loci agr and sar
have been demonstrated to play a role in the induction of
apoptosis in epithelial cells by S. aureus [33]. Mutants in
the agr or sar loci are internalized, but do not induce ap-
optosis [33]. Another study demonstrated induction of
apoptosis in endothelial cells by staphylococcal alpha tox-
in [32].
Wesson et al. [30] demonstrated host caspases-8 and -3 to
play a role inS. aureus-induced apoptosis, and caspase-8 is
known to be associated with apoptosis triggered by en-
gagement of death receptors [35]. Several recent studies
have associated microbial induction of apoptosis with the
production of tumor necrosis factor-related apoptosis-in-
ducing ligand (TRAIL). Measles virus was the first infec-
tious agent shown to induce TRAIL production [36].
Other studies have demonstrated induction of TRAIL by
Theiler's murine encephalomyelitis virus (TMEV) in M1-
D cells (a myelomonocytic precursor cell line) [37], reovi-
rus infection in fibroblasts [38], HIV-1 infection in CD4+
T cells [39], and adenovirus in 239T cells [40]. The dem-
onstration of caspase-8 involvement in S. aureus-induced
apoptosis is complemented by a recent report from our
laboratory that S. aureus induces expression of TRAIL by
infected osteoblasts [41]. We reported that S. aureus
strongly induces TRAIL expression by both normal mouse
and normal human osteoblasts, while mRNAs encoding
the death-domain-containing TRAIL receptors are consti-
tutively expressed in the same cells. S. aureus caused a rap-
id and sustained up-regulation of TRAIL mRNA and TRAIL
protein expression. TRAIL is also secreted by S. aureus-in-
fected osteoblasts, suggesting that TRAIL could influence
cells outside the environment of a localized bacterial
infection.
In the present study, we examined the ability of purified
bacterial surface structures and extracellular products to
induce TRAIL expression in osteoblasts. The ability of
TRAIL produced by S. aureus-infected osteoblasts to medi-
ate osteoblast apoptosis was also examined. Results dem-
onstrate that purified bacterial surface structures and S.
aureus extracellular products present outside osteoblasts
are not a sufficient stimulus for TRAIL induction, and that
physical contact between bacteria and osteoblasts is re-
quired for optimal induction of TRAIL expression. TRAIL
produced by S. aureus-infected osteoblasts does induce
caspase-8 activation and apoptosis. Collectively, these re-
sults reveal TRAIL induction and caspase-8 activation as a
mechanism whereby S. aureus mediates apoptosis in
osteoblasts.BMC Microbiology 2003, 3 http://www.biomedcentral.com/1471-2180/3/5
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Results
Purified bacterial products in the osteoblast extracellular 
environment do not induce TRAIL expression
In order to determine the role of S. aureus-derived pepti-
doglycan and teichoic acid in the expression of TRAIL by
S. aureus-infected osteoblasts, cultured normal human os-
teoblasts were incubated with various concentrations of
these purified cell wall structures (10 ng/ml, 100 ng/ml, or
1 µg/ml). Additionally, osteoblasts were incubated with
various concentrations of staphylococcal enterotoxin A
(SEA; 10 ng/ml, 100 ng/ml, or 1 µg/ml), used here as a
representative superantigen from S. aureus, or with a pu-
rified component of gram-negative bacteria, specifically li-
popolysaccharide (LPS; 10 ng/ml, 100 ng/ml, or 1 µg/ml).
The concentrations of staphylococcal peptidoglycan, tei-
choic acid, SEA, and LPS tested did not induce TRAIL ex-
pression in osteoblasts (Fig. 1). Results for the lower
concentrations of teichoic acid and SEA (10 ng/ml and
100 ng/ml) are not shown. As previously reported [41],
TRAIL protein was induced in osteoblasts infected with S.
aureus (Fig. 1). These results demonstrate that major sur-
face components from these bacteria in a purified form,
present in the osteoblast extracellular environment, are
not sufficient to induce TRAIL expression in normal hu-
man osteoblasts.
Induction of TRAIL by S. aureus requires physical contact 
between bacteria and osteoblasts
Studies indicate that the invasion ability of bacteria are
most relevant to the magnitude of the osteoblast response
[42,43]. In previous experiments examining the produc-
tion of TRAIL by S. aureus-infected osteoblasts, bacteria
were in direct contact with the cells [41], such that the po-
tential of S. aureus extracellular products to induce osteob-
last expression and secretion of TRAIL could not be
addressed. To determine if S. aureus extracellular products
induce TRAIL expression in osteoblasts, normal mouse os-
teoblasts were grown in 12-well cluster plates. S. aureus
strain UAMS-1 at a MOI of 25:1, 75:1, or 250:1 was then
added separately to Transwell® cell culture chamber in-
serts. The inserts were placed into the 12-well plates con-
taining osteoblasts followed by incubation for 45
minutes. The polycarbonate membrane at the base of each
chamber insert contains pores 0.4 µm in size, and pre-
cludes direct interaction between the bacteria and osteob-
lasts. However, the inserts allow for the exchange of
extracellular products. Direct physical contact between S.
aureus and osteoblasts at a MOI of 250:1 induced osteob-
last TRAIL protein expression (Fig. 2). TRAIL protein was
not expressed in osteoblast cultures co-incubated with S.
aureus at various MOIs where physical contact between
the bacteria and osteoblasts was prevented (Fig. 2). These
results demonstrate that physical contact between the
host and pathogen is required for optimal TRAIL induc-
tion. The importance of bacterial internalization, howev-
er, could not be addressed in these experiments.
TRAIL induces apoptosis in osteoblasts
TRAIL may mediate a number of physiological responses;
therefore, in order to determine if TRAIL expressed by S.
aureus-infected osteoblasts mediates osteoblast apoptosis,
cultured normal mouse osteoblasts were infected with S.
aureus strain UAMS-1 at various MOIs in the presence and
absence of an anti-human TRAIL polyclonal antibody. Os-
teoblasts were stained with annexin V and propidium
iodide (PI). Redistribution of phosphotidylserine from
Figure 1
Western immunoblot analysis of TRAIL expression from normal human osteoblasts 24 h following incubation with LPS, pepti-
doglycan, teichoic acid (TA, 1 µg), staphylococcal enterotoxin A (SEA, 1 µg), or following infection with S. aureus at a MOI of 
250:1 (S.a. 250). S. aureus infection was for 45 min, followed by washing and gentamicin treatment of osteoblasts for 24 h prior 
to protein isolation. Ten micrograms of total osteoblast protein were loaded for each lane.BMC Microbiology 2003, 3 http://www.biomedcentral.com/1471-2180/3/5
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the inner leaflet to the outer leaflet of the plasma mem-
brane occurs early and is a hallmark of the apoptotic proc-
ess. Annexin V has a high affinity for phosphatidylserine
and was used to detect apoptotic cells. Propidium iodide
can be used to distinguish early apoptotic cells from late
apoptotic cells. Early apoptotic cells stain positive for an-
nexin V and negative for PI, where as late apoptotic cells
stain positive for both annexin V and PI [44]. After stain-
ing, osteoblasts were analyzed using FACS (Fig. 3). Ap-
proximately 14.89% of the cells from uninfected
osteoblast cultures were annexin V positive. The percent-
age of annexin V-positive cells increased to 32.17% fol-
lowing infection with S. aureus at a MOI of 75:1,
corresponding to a greater than 2-fold increase over that
of uninfected control osteoblast cultures. A 25% reduc-
tion in annexin V-positive cells was observed in the pres-
ence of 1 µg/ml of anti-human TRAIL antibody. A 2 µg/ml
concentration of anti-TRAIL antibody further reduced the
population of annexin V-positive cells to 25.42% of total
osteoblasts, corresponding to an approximately 40% de-
crease in the level of annexin V-positive cells in S. aureus-
infected cultures. A dose-dependent decrease in annexin
V-positive cells was observed by the addition of increasing
amounts of the anti-human TRAIL antibody. These results
strongly suggest TRAIL production induces osteoblast ap-
optosis in S. aureus-infected osteoblast cultures. The role
of TRAIL in S. aureus-induced apoptosis is likely more sig-
nificant than what is revealed by these experiments, since
an anti-human TRAIL antibody was used to neutralize
mouse TRAIL protein. Utilization of an anti-mouse TRAIL
antibody would be predicted to further reduce the level of
S. aureus-induced apoptosis in infected mouse osteoblast
cultures.
S. aureus induces caspase-8 activation in osteoblasts
S. aureus-mediated apoptosis has been reported for a vari-
ety of cells including osteoblasts. A recent report demon-
strated that S. aureus-induced apoptosis of epithelial cells
involves activation of caspases-8 and-3 [30]. To determine
whether caspase-8 is activated in S. aureus-infected osteob-
lasts, cultured normal mouse osteoblasts were infected
with S. aureus strain UAMS-1 at various MOIs. As a posi-
tive control, osteoblasts were stimulated with cyclohex-
imide (CHX), a compound known to induce caspase-8
activation [45]. At various times post-infection, endog-
enous caspase-8 activity was quantified.
Activated caspase-8 was detected in uninfected control os-
teoblast cultures (Fig. 4) and is attributable to apoptosis
and cell turnover in the in vitro osteoblast tissue culture
system. Osteoblasts infected with S. aureus at a MOI of
75:1 demonstrated a 2-fold increase in activated caspase-
8 45 min post-infection, which was significantly higher
than the level of activated caspase-8 in the uninfected con-
trol (p < 0.05) (Fig. 4). This early activation of caspase-8
in S. aureus-infected osteoblasts coincides with previous
observations in other systems. For example, caspase-8 is
activated in HeLa cells within 1 h following the adminis-
tration of TRAIL [46]. The level of caspase-8 activation in
osteoblasts exposed to CHX, a known activator of caspase-
Figure 2
Western immunoblot analysis of TRAIL expression from normal mouse osteoblasts co-cultured with S. aureus. Normal mouse 
osteoblasts were grown in the lower chamber of Transwell plates. S. aureus at a MOI of 25:1, 75:1, or 250:1 was added sepa-
rately to Transwell® cell culture chamber inserts. As a control, osteoblasts were directly infected with S. aureus at a MOI of 
250:1. TRAIL expression was monitored at 45 minutes following the addition of bacteria. Twelve micrograms of total osteob-
last protein was loaded for each lane.BMC Microbiology 2003, 3 http://www.biomedcentral.com/1471-2180/3/5
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8 [45], was significantly higher than the level of activity in
uninfected cells and was equivalent to the level in S. au-
reus-infected osteoblasts (Fig. 4). S. aureus-induced cas-
pase-8 activation was sustained for 2 h following infection
(data not shown). In fact, the levels of activated caspase-8
were significantly higher at 2 h than at 45 min post-infec-
tion in S. aureus-infected osteoblasts.
Caspase-8 has been identified as an initiator caspase acti-
vated in death receptor-mediated apoptosis [47]. There-
fore, we investigated whether blockade of TRAIL expressed
by S. aureus-infected osteoblasts had any effect on the lev-
els of caspase-8 enzymatic activity. Mouse osteoblasts
were infected with S. aureus in the presence of increasing
concentrations of anti-human-TRAIL antibody. Figure 4
demonstrates that anti-TRAIL antibody interferes with cas-
pase-8 activation. A clear dose-response was observed in
the levels of caspase-8 enzymatic activity. As the concen-
trations of the anti-TRAIL antibody increase, the levels of
caspase-8 specific activity decrease. The highest concentra-
tion of anti-TRAIL antibody utilized significantly reduced
the level of caspase-8 enzymatic activity in S. aureus-infect-
ed osteoblast cultures at 45 min and 2 h post-infection (p
< 0.05) (Fig. 4 and data not shown). These results suggest
that caspase-8 activation is mediated by TRAIL, and that
induction of apoptosis by TRAIL utilizes an intracellular
mechanism involving caspase-8 activation.
Discussion
TRAIL is a member of the TNF gene superfamily of recep-
tors and ligands and was discovered based on sequence
homology to other members of the superfamily using an
EST database [48]. Among other family members, TRAIL
is most similar to Fas ligand, sharing 28% homology.
TRAIL can be expressed as a membrane-bound protein or
solubilized by metalloendoproteinase cleavage. The bio-
active form of TRAIL is as a homotrimer [49]. There are
five known human TRAIL receptors, including R1, R2, R3,
R4, and osteoprotegerin (OPG); however, R1 and R2 are
the only TRAIL receptors known to contain complete
death domains. The signaling pathways of TRAIL and its
receptors are not fully known [50]; however, recent stud-
ies suggest TRAIL activates pathways similar to those acti-
vated by TNF and its receptors [49]. Binding of TRAIL to
death-domain containing receptors can cause apoptosis
via activation of caspase-8 in Jurkat and HeLa cells
[46,49].
We have previously demonstrated that S. aureus induces
TRAIL expression in normal human and mouse osteob-
lasts [41]. Messenger RNA encoding TRAIL is rapidly and
dramatically up-regulated following exposure of osteob-
lasts to S. aureus. TRAIL mRNA expression is absent in un-
infected cultures and shows a dose-dependent response to
S. aureus. In contrast to the inducible nature of TRAIL mR-
NA, the messages encoding death-domain-containing
TRAIL receptors are constitutively expressed in human
and mouse osteoblasts [41]. Additionally, TRAIL protein
is expressed and secreted following infection of osteob-
lasts with S. aureus. In contrast, uninfected osteoblasts do
not express significant amounts of TRAIL protein.
The current study examined possible mechanisms where-
by S. aureus induces TRAIL expression in osteoblasts. Os-
teoblasts were incubated with various concentrations of
major surface components of S. aureus, peptidoglycan and
teichoic acid, as well as LPS of gram-negative bacteria to
determine if these were potential inducers of TRAIL ex-
pression. These bacterial components were chosen based
on their ability to induce inflammatory responses. The
two major components of the staphylococcal cell wall,
peptidoglycan and lipoteichoic acid have been reported to
produce inflammation [51,52] and specifically to induce
arthritis [53]. Bacterial peptidoglycan is also known to
stimulate the bone-resorbing activity of macrophages
[54]. Furthermore, staphylococci produce an array of
Figure 3
FACS analysis of normal mouse osteoblasts infected with S. 
aureus at a MOI of 75:1 in the presence or absence of anti-
human TRAIL antibody (1.0 or 2.0 µg/ml). Following a 45-
minute incubation, osteoblasts were washed 3 times with 
HBSS and incubated in medium containing 25 µg of gen-
tamicin per ml to kill extracellular bacteria. Cells were 
stained with annexin V and propidium iodide 24 hours post-
infection and analyzed using FACS. Results are presented 
from one osteoblast culture, and are representative of 
results from three different osteoblast preparations.BMC Microbiology 2003, 3 http://www.biomedcentral.com/1471-2180/3/5
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secreted products capable of inducing or sustaining in-
flammation. For example, the staphylococcal superanti-
gens induce prolonged inflammatory responses
associated with arthritis and destruction of bone connec-
tive tissue [55].
Our results demonstrate that peptidoglycan, teichoic acid,
LPS, and the staphylococcal superantigen staphylococcal
enterotoxin A (SEA), when present in the osteoblast extra-
cellular environment, do not induce TRAIL expression
(Fig. 1). These findings do not eliminate the possibility
that these bacterial structures contribute to TRAIL induc-
tion. They are nevertheless insufficient by themselves to
elicit such a response in osteoblasts exposed extracellular-
ly to the molecules at the concentrations analyzed. The
concentrations of bacterial products chosen were based
on previous reports suggesting these amounts are appro-
priate and sufficient to elicit cytokine responses from hu-
man cells [56,57]. It is possible that one or more of the
purified products analyzed contribute to TRAIL induction,
but only if expressed inside osteoblasts.
While intracellular S. aureus is known to induce TRAIL ex-
pression in osteoblasts [41], the ability of extracellular sta-
phylococcal products to induce TRAIL expression has not
been previously investigated. Results from the Transwell®
co-culture experiments (Fig. 2) demonstrate that extracel-
lular bacterial products do not induce TRAIL expression.
S. aureus at a MOI of 25:1, 75:1, or 250:1 was unable to
induce TRAIL expression when direct contact between
bacteria and osteoblasts was precluded. Even at the high-
est MOI used, no TRAIL was detected in response to the
co-incubation withS. aureus. The bacteria must be in phys-
ical contact, and potentially internalized by the osteob-
lasts, before TRAIL expression is induced. These findings
could indicate that attachment of S. aureus to osteoblasts
Figure 4
Caspase-8 is activated in normal mouse osteoblasts infected with S. aureus at a MOI of 75:1, or following incubation with 10 µg/
ml cycloheximide (CHX). Caspase-8 enzymatic activity was analyzed 45 min following infection. S. aureus-infected osteoblasts 
were incubated for 45 min in the presence of increasing concentrations of anti-human TRAIL antibody (0.5 µg/ml, 1.0 µg/ml, 
and 2.0 µg/ml). Values are presented as the mean +/- standard deviation from three independent osteoblast cultures. Data 
were analyzed utilizing the Student's t-test, *,# P < 0.05.BMC Microbiology 2003, 3 http://www.biomedcentral.com/1471-2180/3/5
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initiates a cascade ultimately inducing TRAIL expression.
Alternatively, intracellular bacteria may be the only S.
aureus  cells capable of inducing TRAIL expression by
osteoblasts.
TRAIL clearly mediates cell death in other tissues, but also
has the potential to mediate a variety of other physiologi-
cal responses in bone. Osteoblasts are known to secrete
tumor necrosis factor-related activation-induced cytokine
(TRANCE) (RANK-L), which acts on the TRANCE receptor
(TRANCE-R) (RANK) found on osteoclast precursors.
Binding of TRANCE to TRANCE-R induces osteoclas-
togenesis and therefore bone resorption. Osteoblasts are
also known to secrete osteoprotegerin (OPG), which
binds TRANCE, thus inhibiting osteoclastogenesis. Be-
cause OPG is a soluble receptor for TRAIL [58], S. aureus-
induced TRAIL secretion could have a profound effect on
both osteoblasts and osteoclasts. Therefore, the ability of
TRAIL expressed by S. aureus-infected osteoblasts to medi-
ate osteoblast apoptosis was examined.
S. aureus induces osteoblast apoptosis [34]. When osteob-
lasts were exposed to S. aureus at a MOI of 75:1, the per-
centages of annexin V-positive cells increased from
14.89% to 32.17% of cells in culture (Fig. 3). Numbers of
annexin V-positive cells were reduced 40% by the addi-
tion of anti-TRAIL antibody (2 µg/ml) to S. aureus-infect-
ed osteoblast cultures. While the antibodies did not
completely inhibit S. aureus-induced apoptosis, these re-
sults demonstrate that TRAIL contributes to apoptosis in
S. aureus-infected cultures. TRAIL-mediated apoptosis of
S. aureus-infected osteoblasts suggests a mechanism
whereby S. aureus induces the bone loss and destruction
associated with osteomyelitis. The inability of the anti-
TRAIL antibodies to completely block apoptosis induced
by S. aureus may be attributable to the specificity of the an-
tibody used for these experiments or the dosage used,
since an anti-human TRAIL antibody was used to neutral-
ize mouse TRAIL protein. The role of TRAIL in S. aureus-
induced apoptosis is therefore likely to be more signifi-
cant than what is revealed by these experiments. Utiliza-
tion of an anti-mouse TRAIL antibody would be predicted
to be more effective in reducing the level of S. aureus-in-
duced apoptosis in infected mouse osteoblast cultures. In
addition, S. aureus may also induce apoptosis by a mech-
anism distinct from TRAIL. It is known, for example, that
S. aureus α-toxin induces apoptosis in Jurkat cells via the
Bcl-2-controlled mitochondrial death pathway [32];
therefore, neutralization of TRAIL would not be expected
to interfere with this mechanism of apoptosis induction.
TRAIL-induced apoptosis involves activation of caspase-8
in other systems. Earlier studies have shown that blockade
of caspase-8 activation in HeLa cells and deletion of cas-
pase-8 in Jurkat cells prevented activation of downstream
signaling, resulting in a failure of the cells to undergo ap-
optosis in response to TRAIL [46]. Similarly, another
group has demonstrated that apoptosis induced by S. au-
reus in bovine mammary epithelial (MAC-T) cells utilizes
a mechanism involving caspases-8 and -3, which are two
key components of the proteolytic cascade that leads to
apoptosis [30]. Results from the current study demon-
strate a two-fold increase in caspase-8 activation upon in-
fection with S. aureus (Fig. 4). Active caspase-8 was
detected in uninfected control osteoblast cultures (Fig. 4),
and is attributable to apoptosis and cell turnover in the in
vitro osteoblast tissue culture systems. The level of activat-
ed caspase-8 in S. aureus-infected osteoblasts was signifi-
cantly higher than the level of activated caspase-8 in
uninfected osteoblast control cultures (p < 0.05). Cas-
pase-8 activation in osteoblasts exposed to CHX was also
higher than the level of activity in uninfected cells, but
equivalent to the level in infected osteoblasts (Fig. 4).
These results demonstrate that S. aureus is a potent induc-
er of caspase-8 activation in osteoblasts, equivalent to a
known inducer of caspase-8 [45]. Overall, the levels of
caspase-8 enzymatic activity at 2 h were significantly high-
er compared to the ones obtained 45 min post-infection
(data not shown). Neutralization of TRAIL by the addi-
tion of the anti-TRAIL antibody interfered with caspase-8
activation, demonstrating a dose-dependent response. As
the concentrations of the anti-TRAIL antibody increased,
the levels of caspase-8 activation decreased. The highest
concentration of antibodies used significantly reduced the
level of caspase-8 activation in S. aureus-infected osteob-
last cultures (p < 0.05). These findings demonstrate that
activation of caspase-8 in S. aureus-infected osteoblasts is
at least in part TRAIL-dependent.
Conclusions
Collectively, these findings reveal that S. aureus induces
apoptosis in osteoblasts via a mechanism involving TRAIL
induction and caspase-8 activation. Induction of TRAIL by
S. aureus requires the bacteria to be in contact with and
potentially internalized by the osteoblasts. Although the
exact mechanism whereby S. aureus induces TRAIL expres-
sion remains to be determined, this study suggests that
major bacterial surface structures present in the osteoblast
extracellular environment do not induce TRAIL. Since
TRAIL mediates a number of physiological responses, the
impact of S. aureus-induced TRAIL expression on normal
bone physiology should be explored. The role of S. aureus-
induced TRAIL in apoptosis and osteoclastogenesis in
vivo is currently being examined.
Methods
Normal mouse osteoblast cell culture
Normal osteoblast cell cultures were prepared from
mouse neonates according to a method previously de-
scribed for chicken embryos [59]. Bone-forming cells wereBMC Microbiology 2003, 3 http://www.biomedcentral.com/1471-2180/3/5
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isolated from mouse neonate calvariae by sequential col-
lagenase and protease digestions. The periostea were
removed, the frontal bones were harvested free of the su-
ture regions, and the bones were incubated for 10 min at
37°C in 10 ml of digestion medium, containing colla-
genase (375 U/ml, type VII; Sigma Chemical Company,
St. Louis, Mo.) and protease (7.5 U/ml; Sigma). The diges-
tion medium and released cells were removed and dis-
carded. Ten milliliters of fresh digestion medium was
added, and incubation was continued for 20 min. Cells
were harvested by centrifugation and rinsed 3 times in 25
mM HEPES-buffered Hanks' balanced salt solution (pH
7.4; HBSS). The digestion step was repeated twice, and the
3 cell isolates were pooled in mouse osteoblast growth
medium (OBGM), consisting of Dulbecco's modified Ea-
gle's medium containing 25 mM HEPES, 10% fetal bovine
serum (Sigma), 2 g of sodium bicarbonate per liter, 75 µg
of glycine/ml, 100 µg of ascorbic acid/ml, 40 ng of vita-
min B12/ml, 2 µg of p-aminobenzoic acid/ml, 200 ng of
biotin/ml, and penicillin (100 U/ml)-streptomycin (100
µg/ml)-amphotericin B (25 µg/ml) (pH 7.4) [60]. Cells
were seeded in six-well cluster plates and incubated at
37°C in a 5% CO2 atmosphere until they reached conflu-
ence (6 to 7 days).
Characterization of normal mouse osteoblasts
Mouse osteoblasts were grown on glass coverslips in 24-
well plates until they were confluent; they were then fixed
and permeabilized using CytoFix/CytoPerm according to
the methods recommended by the manufacturer
(PharMingen, San Diego, Calif.). Rabbit antibodies spe-
cific for osteocalcin (1:100 dilution; Peninsula Laborato-
ries, Belmont, Calif.), type I collagen (1:40 dilution;
Chemicon, Temecula, Calif.), alkaline phosphatase (1:40
dilution; Sigma), or keyhole limpet hemocyanin (1:40 di-
lution) were incubated on cell preparations for 45 min at
4°C. After unbound antibody was washed off, a phyco-
erythrin-conjugated goat anti-rabbit immunoglobulin G
antibody (1:50 dilution; Sigma) was added with incuba-
tion for 45 min at 4°C. After the samples were washed, at
least 500 cells were scored for positive fluorescence using
an Olympus BX60 fluorescence microscope. Osteocalcin,
type I collagen, and alkaline phosphatase were selected for
analysis, since the expression of these proteins has been
used to define osteoblasts as such [61–63].
Normal human osteoblast cultures
Normal human osteoblasts (Clonetics, San Diego, Calif.)
were propagated according to the guidelines provided by
the vendor. Cells were seeded in 25-cm2 flasks and incu-
bated at 37°C in a 5% CO2 atmosphere in medium sup-
plied by the manufacturer; this medium contains 10%
fetal bovine serum, ascorbic acid, and gentamicin. After
the cells reached approximately 80% confluence (5 to 9
days), they were removed from flasks with 0.025%
trypsin-0.01% EDTA, washed in medium, and seeded into
six-well plates. Cells were used as described below once
they reached approximately 80% confluence (6 to 7 days).
These commercially available cells have been extensively
characterized as osteoblasts [61,64].
Bacterial strain and growth conditions
S. aureus strain UAMS-1 (ATCC 49230) (osteomyelitis
clinical isolate) was grown overnight in 5 ml of tryptic soy
broth at 37°C with aeration. Bacteria were harvested by
centrifugation for 10 min at 4,300 × g at 4°C and washed
in 5 ml of HBSS. Bacteria were then resuspended in mouse
OBGM.
Infection and invasion assay
Following resuspension of bacteria in OBGM, bacterial
cell density was determined via spectrophotometric anal-
ysis. Cells were then diluted in OBGM to obtain the de-
sired multiplicity of infection (MOI). Osteoblasts were
infected with S. aureus at a MOI of 25:1, 75:1, or 250:1 (S.
aureus organisms to osteoblasts). The highest MOIs used
resulted in approximately one internalized bacterium per
osteoblast in culture (data not shown). Following a 45
min infection, osteoblasts were washed three times with
HBSS and incubated in medium containing 25 µg of gen-
tamicin per ml to kill extracellular bacteria. At various
times following bacterial invasion, osteoblasts were lysed
and total osteoblast protein isolated for further analysis.
Osteoblast lysis and protein isolation
Osteoblasts were washed twice with phosphate-buffered
saline (PBS) pH 7.4. One ml of PBS was then added to
each tissue culture well and osteoblasts were harvested by
scraping. Osteoblasts in PBS were transferred to microcen-
trifuge tubes and collected by centrifugation at 13,600 × g
for 3 min at 4°C using a Fisher Scientific Micro-Centri-
fuge. Pellets were washed with 1 ml of PBS and then resus-
pended in 100 µl of whole extract lysis buffer (20 mM Tris
pH 7.4, 137 mM NaCl, 25 mM β-glycerolphosphate pH
7.4, 2 mM PPiNa, 2 mM EDTA pH 7.4, 1% Triton X-100,
and 10% glycerol). Following the addition of lysis buffer,
samples were incubated on ice for 15 min and then cen-
trifuged at 13,600 × g for 5 min at 4°C. Cell lysates were
transferred to fresh microcentrifuge tubes. Protein con-
centrations of the cell lysates were quantified as described
[65] and the samples then stored at -80°C until analyzed
by western immunoblot techniques.
Exposure of osteoblasts to purified bacterial products
Cultured normal human osteoblasts were seeded into 6-
well cluster plates in medium provided by the manufac-
turer and incubated at 37°C in a 5% CO2 atmosphere. Af-
ter the cells reached approximately 80% confluence (5 to
9 days), they were treated with purified lipopolysaccha-
ride (LPS), staphylococcal peptidoglycan, teichoic acid, orBMC Microbiology 2003, 3 http://www.biomedcentral.com/1471-2180/3/5
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staphylococcal enterotoxin A (Sigma Chemical Company,
St. Louis, Mo.) over a range of concentrations. Following
a 24 h exposure, osteoblasts were lysed and total osteob-
last proteins isolated and analyzed using western immu-
noblot techniques.
Transwell co-cultures of S. aureus and normal mouse 
osteoblasts
Normal mouse osteoblasts were grown in 12-well cluster
plates containing 1.5 mL of growth medium per well. S.
aureus at an MOI of 25:1, 75:1, or 250:1 was added sepa-
rately to Transwell® cell culture chamber inserts in 0.5 ml
of growth medium. Inserts were placed into the 12-well
plates containing osteoblasts for 45 minutes. The polycar-
bonate membrane at the base of each chamber insert con-
tains pores 0.45 µm in size and precludes direct
interaction between the bacteria and osteoblasts. Howev-
er, the pore size allows for the exchange of extracellular
products. Following the 45-minute incubation, chamber
inserts were removed, osteoblasts lysed and proteins ana-
lyzed using western immunoblot techniques.
FACS analysis of apoptosis
The Vybrant Apoptosis Assay Kit (Molecular Probes, Eu-
gene, OG) was used to detect osteoblast apoptosis. Briefly,
normal mouse osteoblasts were infected with S. aureus
strain UAMS-1 at various MOI in the presence and ab-
sence of an anti-TRAIL polyclonal antibody (rabbit anti-
human TRAIL/Apo2L, Cell Sciences, Inc., Norwood, MA).
Following a 45-minute incubation, osteoblasts were
washed 3 times with HBSS and incubated in medium con-
taining 25 µg of gentamicin per ml to kill extracellular
bacteria. Anti-TRAIL antibody was added to the cultures
again to neutralize any TRAIL produced by the osteoblasts
in response to the infection. At various times post-infec-
tion, osteoblasts were incubated with 0.025% trypsin-
0.01% EDTA for 10 min at 37°C, collected by centrifuga-
tion, washed with PBS, and stained with Alexa Fluor 488
annexin V and propidium iodide according to published
guidelines. Cells were analyzed using a fluorescence-acti-
vated cell sorter (FACSCalibur, Becton Dickinson, San
Jose, CA).
Detection of Caspase-8 activity
Caspase-8 enzymatic activity was detected using a caspase-
8 fluorometric kit (R&D Systems, Minneapolis, MN) ac-
cording to published guidelines. Briefly, cultured normal
mouse osteoblasts were infected with S. aureus in the pres-
ence or absence of anti-TRAIL polyclonal antibody as de-
scribed above or stimulated with cychloheximide (10 µg/
ml). At various time points, osteoblasts were lysed with
lysis buffer and total protein concentration determined as
described [65]. Cell lysates were incubated with the cas-
pase-8 fluorogenic substrate (IETD-AFC) at 37°C for 2 h.
Sample fluorescence was detected using a CytoFluor mul-
ti-well plate reader (Applied Biosystems, Foster City, CA),
where the amount of fluorescence directly corresponds to
the amount of caspase-8 activity.
SDS-PAGE and western immunoblot analysis
Equivalent amounts of protein from the cell lysate frac-
tions described above were mixed with concentrated 2X
sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis (PAGE) loading buffer (0.125 M Tris-HCL [pH
6.8], 4% [wt/vol] SDS, 10% [vol/vol] 2-mercaptoethanol,
20% [vol/vol] glycerol, 0.01% [wt/vol] bromophenol
blue), boiled for 5 min, and cleared by centrifugation at
13,600 × g for 5 min. Osteoblast proteins were separated
by SDS-PAGE as described by Laemmli [66]. The proteins
were then electrophoretically transferred to polyvinyli-
dene difluoride membranes (Fisher Biotech), using the
Mini Trans-Blot apparatus (BioRad, Hercules, CA) at 300
mA for 1 h at 4°C according to manufacturer's recommen-
dations. Membranes were blocked with Buffer A (Tris-
buffered saline (TBS) (Bio-Rad) containing 5.0% skim
milk and 0.5% Tween 20 (Sigma)) for 1 h with gentle
shaking, then washed with Buffer B (TBS containing 0.1%
Tween 20) 3 times for 5 min each. A two-step detection
method was used to identify TRAIL. Blots were first incu-
bated overnight with gentle shaking at 4°C with rabbit
anti-human TRAIL polyclonal antibodies (Cell Sciences,
Inc., Norwood, MA) at a concentration of 0.2 µg/ml in
Buffer A. Membranes were then washed the following day
3 times for 5 min in Buffer B with gentle shaking, then in-
cubated for 1 h with gentle shaking at room temperature
with horseradish peroxidase (HRP)-conjugated anti-rab-
bit immunoglobulin G (Amersham Biosciences Corp.,
Piscataway, NJ) diluted 1:5000 in Buffer A. Reactive pro-
teins were visualized by enhanced chemiluminescence
(Amersham, Arlington Heights, IL) following exposure to
X-ray film and subsequent film development.
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